# EDGAR Filing Document

**Accession Number:** 0001276520
**File Stem:** 0001628280-26-010610
**Filing Date:** 2026-2
**Character Count:** 123024
**Document Hash:** 3f426ebed3004e4b399cfda74d8b9c41
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-010610.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 0001628280-26-010610

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 51

**CONFORMED PERIOD OF REPORT**: 20260223

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260223

**DATE AS OF CHANGE**: 20260223

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENWORTH FINANCIAL INC
- **CENTRAL INDEX KEY:** 0001276520
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 800873306
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32195
- **FILM NUMBER:** 26665287

**BUSINESS ADDRESS:**
- **STREET 1:** 11011 WEST BROAD STREET
- **CITY:** GLEN ALLEN
- **STATE:** VA
- **ZIP:** 23060
- **BUSINESS PHONE:** 804-281-6000

**MAIL ADDRESS:**
- **STREET 1:** 11011 WEST BROAD STREET
- **CITY:** GLEN ALLEN
- **STATE:** VA
- **ZIP:** 23060

?xml version='1.0' encoding='ASCII'? gnw-20260223

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

___________________________________________________________

**FORM 8-K**

___________________________________________________________

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

February 23, 2026

**Date of Report**

**(Date of earliest event reported)**

___________________________________________________________

![Image_1.jpg](gnw-20260223_g1.jpg)

**GENWORTH FINANCIAL, INC.**

**(Exact name of registrant as specified in its charter)**

___________________________________________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-32195** | **80-0873306** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission<br>File Number)** | **(I.R.S. Employer<br>Identification No.)** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**11011 West Broad Street, Glen Allen, Virginia** | **23060** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(Address of principal executive offices)** | **(Zip Code)** |

---

**(804) 281-6000**

**(Registrant's telephone number, including area code)**

**N/A**

**(Former name or former address, if changed since last report)**

___________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

□ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

□ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

□ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

□ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol** | **Name of each exchange<br>on which registered** |
| Common Stock, par value $.001 per share | GNW | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

------

---

| | |
|:---|:---|
| **Item 2.02** | **Results of Operations and Financial Condition.** |

---

On February 23, 2026, Genworth Financial, Inc. (the "Company") issued (1) a press release announcing its financial results for the quarter ended December 31, 2025, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, and (2) a financial supplement for the quarter ended December 31, 2025, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K (including the exhibits) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the company under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

The following materials are furnished as exhibits to this Current Report on Form 8-K:

---

| | |
|:---|:---|
| Exhibit<br>Number | Description of Exhibit |
| 99.1 | <u>[Press Release dated February 23, 2026](quarterlyearningsrelease.htm)</u> |
| 99.2 | <u>[Financial Supplement for the quarter ended December 31, 2025](a4q25quarterlyfinancials.htm)</u> |
| 104 | Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document) |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | GENWORTH FINANCIAL, INC. | GENWORTH FINANCIAL, INC. |
| Date: February 23, 2026 | By: | /s/ Darren W. Woodell |
|  |  | Darren W. Woodell |
|  |  | Vice President and Controller |
|  |  | (Principal Accounting Officer) |

---

## Exhibit 99.1

**Exhibit 99.1**

![pressreleaseimage1a.jpg](pressreleaseimage1a.jpg)

**Genworth Financial Announces Fourth Quarter 2025 Results** 

**Strategic Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Delivered 925 matches with home care providers<sup>1</sup> in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Closed acquisition of Seniorly, Inc. for total cash consideration of $15M

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Care Assurance launched in October and was live in 39 states as of December 31, 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Continued progress on the LTC<sup>2</sup> MYRAP<sup>3</sup> with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs<sup>4</sup>

**Financial Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income<sup>5</sup> of $223M, or $0.54 per diluted share, and adjusted operating income<sup>5,6</sup> of $144M, or $0.35<sup>6</sup> per diluted share in 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income<sup>5</sup> of $2M and adjusted operating income<sup>5,6</sup> of $8M in the quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enact reported adjusted operating income of $146M<sup>5</sup> in the quarter; distributed $127M in capital returns to Genworth, PMIERs sufficiency ratio<sup>7</sup> remains strong at 162%<sup>8</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Completed Closed Block<sup>9</sup> annual assumption updates with net unfavorable impacts of $6M to the adjusted operating loss in the quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Legacy insurance companies'<sup>10</sup> RBC ratio<sup>11</sup> of 300%<sup>8</sup> and statutory pre-tax income of $71M<sup>8</sup> in 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Genworth holding company cash and liquid assets of $234M<sup>12</sup> at quarter-end

Richmond, VA (February 23, 2026) – Genworth Financial, Inc. (NYSE: GNW) today reported results for the quarter ended December 31, 2025.

---

| | |
|:---|:---|
| ![picture1a.jpg](picture1a.jpg) | "Genworth delivered strong results in 2025 as we continued to execute against our strategic priorities," said Tom McInerney, President & CEO. "We took major steps to advance CareScout's strategy, with nationwide expansion of the CareScout Quality Network, the launch of Care Plans, our new innovative consumer-facing solution, along with the launch and continued buildout of our CareScout insurance offerings. With Enact as a durable source of cash flows, a growing and increasingly integrated CareScout platform, and disciplined management of our legacy insurance businesses, we are delivering long-term value for shareholders while supporting millions of families navigating the aging journey." |

---

------

---

| | | | |
|:---|:---|:---|:---|
| **Consolidated Metrics**<br>*(Amounts in millions, except per share data)* | **Q4 2025** | **Q3 2025** | **Q4 2024** |
| Net income (loss)<sup>5</sup> | $2 | $116 | $(1) |
| Net income (loss) per diluted share<sup>5</sup> | $— | $0.28 | $— |
| Adjusted operating income (loss)<sup>5,6</sup> | $8 | $17 | $15 |
| Adjusted operating income (loss) per diluted share<sup>5,6</sup> | $0.02 | $0.04 | $0.04 |
| Weighted-average diluted shares<sup>13</sup> | 396.4 | 413.3 | 431.0 |

---

**<u>Consolidated GAAP Financial Highlights</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Beginning in the fourth quarter of 2025, the company changed its reportable segments to better align with how it currently manages the business. Under the new reporting structure, the company operates its business through the following two reportable segments: Enact, comprised primarily of private mortgage insurance products, and Closed Block, comprised of long-term care insurance, life insurance and annuity products that were previously sold under the legacy insurance companies. Financial information has been updated for all periods

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income was driven by Enact, which had strong operating performance

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net investment income, net of taxes, was $620 million in the quarter, down from $631 million in the prior quarter and $626 million in the prior year primarily from lower income from limited partnerships

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net investment losses, net of taxes, decreased net income by $31 million in the quarter, compared with net investment gains of $78 million in the prior quarter and net investment losses of $32 million in the prior year. The investment losses in the current quarter were driven primarily by net trading losses and mark-to-market adjustments on limited partnerships

------

**<u>Enact</u>**

---

| | | | |
|:---|:---|:---|:---|
| **GAAP Operating Metrics**<br>*(Dollar amounts in millions)* | **Q4 2025** | **Q3 2025** | **Q4 2024** |
| Adjusted operating income (loss)<sup>5</sup> | $146 | $134 | $137 |
| Primary new insurance written | $14386 | $14048 | $13266 |
| Loss ratio | 7% | 15% | 10% |
| Equity<sup>14</sup> | $4351 | $4320 | $4068 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Results included a pre-tax net reserve release of $60 million reflecting favorable cure performance and the lowering of claim rate expectations. The prior quarter and prior year included pre-tax reserve releases of $45 million and $56 million, respectively

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pre-tax net investment income of $69 million was up from $62 million in the prior year from higher yields and higher invested assets

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Primary insurance in-force increased 2% versus the prior year to $273.1 billion driven by new insurance written (NIW) and continued elevated persistency

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Primary NIW was up 2% from the prior quarter and 8% from the prior year

---

| | | | |
|:---|:---|:---|:---|
| **Capital Metric** | **Q4 2025** | **Q3 2025** | **Q4 2024** |
| PMIERs sufficiency ratio<sup>7,8</sup> | 162% | 162% | 167% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In February 2026, Enact announced a new share repurchase program with authorization to purchase up to $500 million of common stock

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enact announced an excess of loss reinsurance agreement covering the 2027 book year

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Enact paid a quarterly dividend of $0.21 per share

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Estimated PMIERs sufficiency ratio of 162%, $1,919 million above requirements

------

**<u>Closed Block</u>**

---

| | | | |
|:---|:---|:---|:---|
| **GAAP Adjusted Operating Income (Loss)**<br>*(Amounts in millions)* | **Q4 2025** | **Q3 2025** | **Q4 2024** |
| Long-term care insurance | $(159) | $(100) | $(104) |
| Life insurance | 13 | (15) | 2 |
| Annuities | 32 | 19 | 3 |
| **Total Closed Block** | $**(114)** | $**(96)** | $**(99)** |

---

***Long-term care insurance***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current quarter loss included unfavorable A/E<sup>15</sup> of $124 million pre-tax primarily from higher claims and lower terminations and an unfavorable impact from assumption updates of $47 million pre-tax

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Unfavorable assumption updates in the current quarter were primarily related to benefit utilization and healthy life mortality and incidence updates that align with near-term experience, largely offset by updates reflecting favorable approval experience and benefit reductions and claim termination rates

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Prior quarter loss included unfavorable A/E of $107 million pre-tax primarily from lower terminations and higher benefit utilization

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Prior year loss included unfavorable A/E of $97 million pre-tax primarily from lower terminations and higher claims and an unfavorable impact from assumption updates of $20 million pre-tax

***Life insurance***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current quarter income reflects favorable interest rate assumption updates of $15 million pre-tax

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Prior year included a net favorable impact of $30 million pre-tax from a model refinement and assumption updates

***Annuities***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current quarter income reflects favorable impact from annual assumption updates of $25 million pre-tax primarily related to mortality compared to unfavorable updates of $18 million pre-tax in the prior year

**<u>Corporate and Other</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The current quarter adjusted operating loss was $24 million, up from $21 million in the prior quarter and $23 million in the prior year primarily driven by continued investment in CareScout and debt service, partially offset by favorable tax-related items

------

**<u>Legacy Insurance Companies</u>**<sup>10</sup> **<u>Statutory Results</u>**<sup>8</sup> **<u>and RBC Ratio</u>**<sup>8</sup>

---

| | | | |
|:---|:---|:---|:---|
| *(Dollar amounts in millions)* | **Q4 2025** | **Q3 2025** | **Q4 2024** |
| Statutory pre-tax income (loss)<sup>8,16</sup> | $3 | $(12) | $(33) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term care insurance | (84) | (75) | (78) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Life insurance | 60 | (2) | 49 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annuities | 27 | 65 | (4) |
| GLIC consolidated RBC ratio<sup>8,11</sup> | 300% | 303% | 306% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Statutory pre-tax income was $71 million in 2025, with $3 million in the current quarter

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• LTC continued to benefit from premium increases and benefit reductions from IFAs. Results reflected higher claims and lower reserve releases from in-force rate actions, largely offset by higher income from limited partnerships than the prior quarter. The current quarter included an unfavorable $12 million pre-tax impact from assumption updates; prior year included a $79 million increase in cash flow testing reserves in GLICNY, partially offset by a net $20 million pre-tax benefit from assumption updates

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Life insurance results included a net benefit from assumption updates of $51 million compared to $75 million in the prior year and favorable reserve changes from block runoff

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Annuity results reflected favorable net equity market and interest rate impacts and unfavorable assumption updates, though lower than the prior year

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current quarter estimated GLIC consolidated RBC ratio was 300%, down from the prior year driven by higher required capital as the limited partnership portfolio grows, partially offset by statutory earnings in the year.

**<u>Holding Company Cash and Liquid Assets</u>**

---

| | | | |
|:---|:---|:---|:---|
| *(Amounts in millions)* | **Q4 2025** | **Q3 2025** | **Q4 2024** |
| Holding company cash and liquid assets<sup>12,17</sup> | $234 | $254 | $294 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash and liquid assets were $234 million at the end of the current quarter, which included approximately $127 million of cash held for future obligations, including advance cash payments from the company's subsidiaries

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash inflows during the current quarter included $127 million from Enact capital returns

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current quarter cash outflows included $96 million<sup>18</sup> in share repurchases, $22 million in net tax payments, $18 million related to debt servicing costs and the repurchase of $7 million in principal of holding company debt at a discount

***Capital Allocation and Shareholder Returns***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Executed $94 million in share repurchases in the quarter at an average price of $8.66 per share

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Executed $790 million in share repurchases since the program's inception through December 31, 2025 at an average price of $6.21 per share

------

**About Genworth Financial**

Genworth Financial, Inc. (NYSE: GNW) is a publicly traded holding company headquartered in Richmond, Virginia. Through its family of brands—including CareScout, Genworth, and Enact—Genworth uses its more than 150 years of experience to help families navigate the aging journey with clarity and confidence, offering guidance, products, and services that support caregiving decisions, long-term care planning, and the financial challenges of aging. Genworth is the majority owner of Enact Holdings, Inc. (Nasdaq: ACT), a leading U.S. mortgage insurance provider. For more information, visit <u>https://www.genworth.com</u>.

**Conference Call Information** 

Investors are encouraged to read this press release, summary presentation and financial supplement which are now posted on the company's website, <u>https://investor.genworth.com</u>.

Genworth will conduct a conference call on February 24, 2026 at 9:00 a.m. (ET) to discuss its fourth quarter results, which will be accessible via:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Telephone: 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID # 5373572; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Webcast: <u>https://investor.genworth.com/news-events/ir-calendar</u>

Allow at least 15 minutes prior to the call time to register for the call. A replay of the webcast will be available on the company's website for one year.

**Contact Information:** 

---

| | |
|:---|:---|
| Investors: | Christine Jewell |
| | <u>InvestorInfo@genworth.com</u> |
| Media: | Evans Mandes |
| | <u>Evans.Mandes@genworth.com</u> |

---

------

**Use of Non-GAAP Measures** 

Management evaluates performance and allocates resources based on a non-GAAP financial measure entitled "adjusted operating income (loss)." Management evaluates adjusted operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects overall operating performance, as it minimizes the impact of macroeconomic volatility. GLIC and its subsidiaries, which comprise the Closed Block segment, are managed on a standalone basis; therefore, the company does not allocate capital to its Closed Block segment.

The company defines adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of the company's net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to the company's discretion and are influenced by market opportunities, as well as asset-liability matching considerations. The company excludes net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in the company's opinion, they are not indicative of overall operating performance.

While some of these items may be significant components of net income (loss) determined in accordance with GAAP, the company believes that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with GAAP. In addition, the company's definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% current tax rate, plus any associated deferred taxes, and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

The table at the end of this press release provides a reconciliation of net income (loss) available to Genworth Financial, Inc.'s common stockholders to adjusted operating income (loss) for the three and twelve months ended December 31, 2025 and 2024, as well as the three months ended September 30, 2025 and reflects adjusted operating income (loss) as determined in accordance with accounting guidance related to segment reporting.

**Statutory Accounting Data** 

The company presents certain supplemental statutory data for GLIC and its consolidating life insurance subsidiaries that has been prepared on the basis of statutory accounting principles (SAP). GLIC and its consolidating life insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners that are prepared using SAP, an accounting basis either prescribed or permitted by such authorities. Due to differences in methodology between SAP and GAAP, the values for assets, liabilities and equity, and the recognition of income and expenses, reflected in financial statements prepared in accordance with GAAP are materially different from those reflected in financial statements prepared under SAP. This supplemental statutory data should not be viewed as an alternative to, or used in lieu of, GAAP.

This supplemental statutory data includes the company action level RBC ratio for GLIC and its consolidating life insurance subsidiaries as well as combined statutory pre-tax earnings from the principal legacy insurance companies, GLIC, GLAIC and GLICNY. Statutory pre-tax earnings represent the net gain from operations, including the impact from in-force rate actions, before dividends to policyholders, refunds to members and federal income taxes and before realized capital gains or (losses). The combined product level statutory pre-tax earnings are grouped on a consistent basis as those provided on page six of the statutory Annual Statements. Management uses and provides this supplemental statutory data because it believes it provides a useful measure of, among other things, statutory pre-tax earnings and the adequacy of capital. Management uses this data to measure against its policy to manage the legacy insurance companies with internally generated capital.

------

**Cautionary Note Regarding Forward-Looking Statements** 

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates," "will," "may" or words of similar meaning and include, but are not limited to, statements regarding the outlook for the company's future business and financial performance. Examples of forward-looking statements include statements the company makes relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (Enact Holdings), including share repurchases, and quarterly and special dividends; the cumulative economic benefit of approved and future rate increases and benefit reductions included in the multi-year in-force rate action plan and other reduced benefit options associated with the long-term care insurance products in the company's Closed Block segment; planned investments in and the company's outlook for new lines of business or new insurance and other products and services, such as those it is pursuing with its CareScout business (CareScout), including through its CareScout services business (CareScout Services) and its CareScout insurance business (CareScout Insurance); the expected benefits and/or synergies of the Seniorly, Inc. (Seniorly) acquisition; future financial performance, including the expectation that quarterly adverse variances between actual and expected experience could persist resulting in future remeasurement losses in the company's long-term care insurance products in its Closed Block segment; the resolution of the appeal or any potential litigation recovery amounts in connection with the AXA S.A. (AXA) and Santander Cards UK Limited (Santander) litigation, and Genworth's planned use of proceeds from any recovery in connection with the litigation, including share repurchases, debt repurchases and investments in new businesses; future financial condition and liquidity of the company's businesses; and statements the company makes regarding the outlook of the U.S. economy.

Forward-looking statements are based on management's current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the inability to successfully launch new lines of business, including long-term care insurance and other products and services the company is pursuing with CareScout;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the company's failure to maintain the self-sustainability of its legacy insurance subsidiaries, including as a result of the inability to achieve desired levels of in-force management actions and/or the timing of future premium rate increases and associated benefit reductions taking longer to achieve than originally assumed; other regulatory actions negatively impacting the company's life insurance businesses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing and the need to seek additional capital on unfavorable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact on any potential recovery in the AXA and Santander litigation resulting from a successful appeal, significant delays or any other adverse development in the litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adverse changes to the structure or requirements of Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac) or the U.S. mortgage insurance market; an increase in the number of loans insured through federal government mortgage insurance programs, including those offered by the Federal Housing Administration; the inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by PMIERs (or any adverse changes thereto), the inability to meet minimum statutory capital requirements of applicable regulators or the mortgage insurer eligibility requirements of Fannie Mae or Freddie Mac;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in economic, market and political conditions, labor shortages and fluctuating interest rates; unanticipated financial events, which could lead to market-wide liquidity problems and other significant market disruption resulting in losses, defaults or credit rating downgrades of other financial institutions; deterioration in economic conditions, a recession or a decline in home prices, all of which could be driven by many potential factors, including a U.S. federal government shutdown; an increase in the cost of care impacting the company's long-term care insurance products included in its Closed Block segment; changes in international trade policy, including the potential impact of new or increased tariffs, retaliatory policies or actions from other countries, and trade wars or other events that lead to political and economic instability; changes in government or monetary policies; changes within regulatory agencies; changes in immigration policy; and fluctuations in international securities markets;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• downgrades in financial strength and credit ratings and potential adverse impacts to liquidity; counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of invested assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in tax rates or tax laws, or changes in accounting and reporting standards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the inability to retain, attract and motivate qualified employees or senior management;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in the composition of Enact Holdings' business or undue concentration by customer or geographic region;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact from deficiencies in the company's disclosure controls and procedures or internal control over financial reporting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the occurrence of natural or man-made disasters, including geopolitical tensions and war (including the Russian invasion of Ukraine, instability in the Middle East and economic competition between the United States and China, among others), a public health emergency, including pandemics, or climate change;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the inability to effectively manage information technology systems (including artificial intelligence), cyber incidents or other failures, disruptions or security breaches of the company or its third-party vendors, as well as unknown risks and uncertainties associated with artificial intelligence;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the inability of third-party vendors to meet their obligations to the company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the lack of availability, affordability or adequacy of reinsurance to protect the company against losses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unanticipated claims resulting from Enact Holdings' delegated underwriting and loss mitigation programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of medical advances such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• other factors described in the risk factors contained in Item 1A of the company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on February 28, 2025.

The company provides additional information regarding these risks and uncertainties in its Annual Report on Form 10-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Accordingly, for the foregoing reasons, the company cautions the reader against relying on any forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws.

------

**Condensed Consolidated Statements of Income (Loss)**

**(Amounts in millions, except per share amounts)** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended December 31,** | **Three months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Three months ended September 30, 2025** |
| | **2025** | **2024** | **2025** | **2024** | **Three months ended September 30, 2025** |
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | | **(Unaudited)** |
| Revenues: |  |  |  |  |  |
| Premiums | $886 | $876 | $3499 | $3480 | $886 |
| Net investment income | 785 | 793 | 3125 | 3160 | 799 |
| Net investment gains (losses) | (39) | (41) | 59 | 13 | 99 |
| Policy fees and other income | 152 | 154 | 618 | 642 | 151 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 1784 | 1782 | 7301 | 7295 | 1935 |
| Benefits and expenses: |  |  |  |  |  |
| Benefits and other changes in policy reserves | 1182 | 1199 | 4821 | 4766 | 1227 |
| Liability remeasurement (gains) losses | 143 | 88 | 313 | 153 | 106 |
| Changes in fair value of market risk benefits and associated hedges | (4) | (3) | 3 | (13) | (1) |
| Interest credited | 97 | 101 | 386 | 453 | 96 |
| Acquisition and operating expenses, net of deferrals | 265 | 253 | 1009 | 977 | 259 |
| Amortization of deferred acquisition costs and intangibles | 57 | 62 | 231 | 249 | 57 |
| Interest expense | 26 | 27 | 105 | 115 | 27 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total benefits and expenses | 1766 | 1727 | 6868 | 6700 | 1771 |
| Income (loss) from continuing operations before income taxes | 18 | 55 | 433 | 595 | 164 |
| Provision (benefit) for income taxes | 4 | 20 | 84 | 158 | 9 |
| Income (loss) from continuing operations | 14 | 35 | 349 | 437 | 155 |
| Income (loss) from discontinued operations, net of taxes | 21 | (5) | 1 | (10) | (8) |
| Net income (loss) | 35 | 30 | 350 | 427 | 147 |
| Less: net income (loss) attributable to noncontrolling interests | 33 | 31 | 127 | 128 | 31 |
| Net income (loss) available to Genworth Financial, Inc.'s common stockholders | $2 | $(1) | $223 | $299 | $116 |
| Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.05) | $0.01 | $0.54 | $0.71 | $0.30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.05) | $0.01 | $0.54 | $0.70 | $0.30 |
| Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $— | $— | $0.54 | $0.69 | $0.29 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $— | $— | $0.54 | $0.68 | $0.28 |
| Weighted-average common shares outstanding: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 396.4 | 425.3 | 409.0 | 433.9 | 408.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted<sup>13</sup> | 396.4 | 431.0 | 414.0 | 439.4 | 413.3 |

---

------

**Reconciliation of Net Income (Loss) to Adjusted Operating Income (Loss)** 

**(Amounts in millions, except per share amounts)** 

**(Unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended December 31,** | **Three months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Three months ended September 30, 2025** |
| | **2025** | **2024** | **2025** | **2024** | **Three months ended September 30, 2025** |
| Net income (loss) available to Genworth Financial, Inc.'s common stockholders | $2 | $(1) | $223 | $299 | $116 |
| Add: net income (loss) attributable to noncontrolling interests | 33 | 31 | 127 | 128 | 31 |
| Net income (loss) | 35 | 30 | 350 | 427 | 147 |
| Less: income (loss) from discontinued operations, net of taxes | 21 | (5) | 1 | (10) | (8) |
| Income (loss) from continuing operations | 14 | 35 | 349 | 437 | 155 |
| Less: net income (loss) from continuing operations attributable to noncontrolling interests | 33 | 31 | 127 | 128 | 31 |
| Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders | (19) | 4 | 222 | 309 | 124 |
| Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders: |  |  |  |  |  |
| Net investment (gains) losses, net<sup>19</sup> | 38 | 39 | (62) | (17) | (99) |
| Changes in fair value of market risk benefits attributable to changes in interest rates, equity markets and associated hedges<sup>20</sup> | (6) | (24) | (5) | (43) | (3) |
| (Gains) losses on early extinguishment of debt, net<sup>21</sup> | (1) | (2) | (1) | 2 |  |
| Expenses related to restructuring |  | 1 |  | 12 | 1 |
| Taxes on adjustments<sup>22</sup> | (4) | (3) | (10) | 10 | (6) |
| Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders | $8 | $15 | $144 | $273 | $17 |
| Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders: |  |  |  |  |  |
| Enact segment | $146 | $137 | $558 | $585 | $134 |
| Closed Block segment: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term care insurance | (159) | (104) | (326) | (176) | (100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Life insurance | 13 | 2 | (66) | (94) | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annuities | 32 | 3 | 75 | 56 | 19 |
| Closed Block segment | (114) | (99) | (317) | (214) | (96) |
| Corporate and Other | (24) | (23) | (97) | (98) | (21) |
| Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders | $8 | $15 | $144 | $273 | $17 |
| Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $— | $— | $0.54 | $0.69 | $0.29 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $— | $— | $0.54 | $0.68 | $0.28 |
| Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders per share: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.02 | $0.04 | $0.35 | $0.63 | $0.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.02 | $0.04 | $0.35 | $0.62 | $0.04 |
| Weighted-average common shares outstanding: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 396.4 | 425.3 | 409.0 | 433.9 | 408.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted<sup>13</sup> | 396.4 | 431.0 | 414.0 | 439.4 | 413.3 |

---

------

**<u>Footnote Definitions</u>**

<sup>1</sup>A match with a home care provider is identified when CareScout validates and approves an invoice from a CareScout Quality Network provider that demonstrates a CareScout member has received services for the first time, and the appropriate discount was applied.

<sup>2</sup>Long-term care insurance.

<sup>3</sup>Multi-year rate action plan.

<sup>4</sup>In-force rate actions.

<sup>5</sup>All references reflect amounts available to Genworth's common stockholders.

<sup>6</sup>This is a financial measure that is not calculated based on U.S. Generally Accepted Accounting Principles (GAAP). See the Use of Non-GAAP Measures section of this press release for additional information.

<sup>7</sup>The Private Mortgage Insurer Eligibility Requirements (PMIERs) sufficiency ratio is calculated as available assets divided by required assets as defined within PMIERs.

<sup>8</sup>Company estimate for the fourth quarter of 2025 due to timing of the preparation and filing of the statutory financial statement(s).

<sup>9</sup>Beginning in the fourth quarter of 2025, the company changed its reportable segments—the Closed Block segment is comprised of long-term care insurance, life insurance and annuity products.

<sup>10</sup>Genworth's legacy insurance companies: GLIC, Genworth Life and Annuity Insurance Company (GLAIC) and Genworth Life Insurance Company of New York (GLICNY).

<sup>11</sup>Risk-based capital ratio based on company action level for Genworth Life Insurance Company (GLIC) consolidated.

<sup>12</sup>Includes approximately $127 million, $145 million and $186 million of cash held for future obligations, including advance cash payments from the company's subsidiaries as of December 31, 2025, September 30, 2025 and December 31, 2024, respectively.

<sup>13</sup>Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of the loss from continuing operations for the three months ended December 31, 2025, the company was required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended December 31, 2025, as the inclusion of shares for performance stock units, restricted stock units and other equity-based awards of 6.0 million would have been antidilutive to the calculation. If the company had not incurred a loss from continuing operations for the three months ended December 31, 2025, dilutive potential weighted-average common shares outstanding would have been 402.4 million.

<sup>14</sup>Reflects Genworth's ownership of equity including accumulated other comprehensive income (loss) and excluding noncontrolling interests of $1,017 million, $1,009 million and $937 million as of December 31, 2025, September 30, 2025 and December 31, 2024, respectively.

<sup>15</sup>Actual variances from expected experience.

<sup>16</sup>Net gain (loss) from operations before dividends to policyholders, refunds to members and federal income taxes for GLIC, GLAIC and GLICNY, and before realized capital gains or (losses).

<sup>17</sup>Holding company cash and liquid assets comprises assets held in Genworth Holdings, Inc. (the issuer of outstanding public debt) which is a wholly-owned subsidiary of Genworth Financial, Inc.

<sup>18</sup>Includes $2 million of share repurchases executed in the third quarter of 2025 but settled in the fourth quarter of 2025.

<sup>19</sup>Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $1 million and $2 million for the three months ended December 31, 2025 and 2024, respectively, and $3 million and $4 million for the twelve months ended December 31, 2025 and 2024, respectively.

<sup>20</sup>Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(2) million and $(21) million for the three months ended December 31, 2025 and 2024, respectively, $(8) million and $(30) million for the twelve months ended December 31, 2025 and 2024, respectively, and $(2) million for the three months ended September 30, 2025.

<sup>21</sup>(Gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million for the twelve months ended December 31, 2024.

<sup>22</sup>Taxes on adjustments included tax expense (benefits) of $3 million and $(24) million for the three and twelve months ended December 31, 2025, respectively, and $(27) million for the three months ended September 30, 2025 related to a release of a portion of the valuation allowance on certain deferred tax assets.

## Exhibit 99.2

![](a4q25quarterlyfinancials001.jpg)

Fourth Quarter Financial Supplement December 31, 2025 Exhibit 99.2

------

![](a4q25quarterlyfinancials002.jpg)

**Table of Contents** Page Investor Letter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Use of Non-GAAP Measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Results of Operations and Selected Operating Performance Measures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Financial Highlights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Consolidated Quarterly Results Consolidated Net Income (Loss) by Quarter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Reconciliation of Net Income (Loss) to Adjusted Operating Income (Loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Consolidated Balance Sheets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10-11 Consolidated Balance Sheets by Segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12-13 Quarterly Results by Business Adjusted Operating Income (Loss) and Selected Operating Metrics - Enact Segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15-16 Adjusted Operating Income (Loss) and Selected Operating Metrics - Closed Block Segment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18-23 Adjusted Operating Income (Loss) - Corporate and Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Additional Financial Data Investments Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Fixed Maturity Securities Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 U.S. GAAP Net Investment Income Yields . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 Net Investment Gains (Losses) - Detail . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Reconciliations of Non-GAAP Measures Reconciliation of Operating Return On Equity (ROE) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 Reconciliation of Consolidated Expense Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Reconciliation of Reported Yield to Core Yield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 Note: Unless otherwise stated, all references in this financial supplement to income (loss) from continuing operations, income (loss) from continuing operations per share, net income (loss), net income (loss) per share, adjusted operating income (loss), adjusted operating income (loss) per share, book value and book value per share should be read as income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders, income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share, net income (loss) available to Genworth Financial, Inc.'s common stockholders, net income (loss) available to Genworth Financial, Inc.'s common stockholders per share, non-U.S. Generally Accepted Accounting Principles (U.S. GAAP) adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders, non-GAAP adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders per share, book value available to Genworth Financial, Inc.'s common stockholders and book value available to Genworth Financial, Inc.'s common stockholders per share, respectively. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 2

------

![](a4q25quarterlyfinancials003.jpg)

Dear Investor, Thank you for your continued interest in Genworth Financial, Inc. Please see the accompanying press release and summary presentation posted to the company's website at https://investor.genworth.com for additional information regarding its fourth quarter 2025 earnings results. In October 2025, the company began selling an individual long-term care insurance product through its CareScout Insurance subsidiary, CareScout Insurance Company, and ceased sales of long-term care insurance products through Genworth Life Insurance Company (GLIC). In connection with the cessation of sales through GLIC, beginning in the fourth quarter of 2025, the company changed its reportable segments to better align with how it currently manages its business. Under the new reporting structure, the company operates its business through the following two reportable segments: Enact, comprised primarily of private mortgage insurance products, and Closed Block, comprised of long- term care insurance, life insurance and annuities products that were previously sold through GLIC and its subsidiaries (collectively referred to as the company's legacy insurance subsidiaries). In addition to its two reportable segments, the company discloses other business activities and operating results in Corporate and Other, including its start-up businesses, CareScout Services and CareScout Insurance. The company believes the change helps to enhance understanding of business performance and better aligns with its strategic priorities, including to maintain self-sustaining legacy insurance subsidiaries, which are managed on a standalone basis. All prior period financial information has been recast to reflect the reorganized segment reporting structure. The company has added insurance in-force for its life insurance products on page 22 of this financial supplement. Investors are encouraged to listen to the company's earnings call on the fourth quarter 2025 results at 9:00 a.m. (ET) on February 24, 2026. The company's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 24 conference call is 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID #5373572. To participate in the call by webcast, register at least 15 minutes in advance at https://investor.genworth.com. Regards, Christine Jewell Investor Relations InvestorInfo@genworth.com GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 3

------

![](a4q25quarterlyfinancials004.jpg)

Use of Non-GAAP Measures Management evaluates performance and allocates resources based on a non-GAAP financial measure entitled "adjusted operating income (loss)." Management evaluates adjusted operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects overall operating performance, as it minimizes the impact of macroeconomic volatility. The company's legacy insurance subsidiaries, which comprise the Closed Block segment, are managed on a standalone basis; therefore, the company does not allocate capital to its Closed Block segment. The company defines adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of the company's net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to the company's discretion and are influenced by market opportunities, as well as asset-liability matching considerations. The company excludes net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in the company's opinion, they are not indicative of overall operating performance. While some of these items may be significant components of net income (loss) determined in accordance with U.S. GAAP, the company believes that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with U.S. GAAP. In addition, the company's definition of adjusted operating income (loss) may differ from the definitions used by other companies. Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% current tax rate, plus any associated deferred taxes, and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments. The table on page 9 of this financial supplement provides a reconciliation of net income (loss) to adjusted operating income (loss) for the periods presented and reflects adjusted operating income (loss) as determined in accordance with accounting guidance related to segment reporting. This financial supplement includes other non-GAAP measures management believes enhances the understanding and comparability of performance by highlighting underlying business activity and profitability drivers. These additional non-GAAP measures are on pages 32 to 34 of this financial supplement. Statutory Accounting Data The company presents certain supplemental statutory data for GLIC and its consolidating life insurance subsidiaries that has been prepared on the basis of statutory accounting principles (SAP). GLIC and its consolidating life insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners that are prepared using SAP, an accounting basis either prescribed or permitted by such authorities. Due to differences in methodology between SAP and U.S. GAAP, the values for assets, liabilities and equity, and the recognition of income and expenses, reflected in financial statements prepared in accordance with U.S. GAAP are materially different from those reflected in financial statements prepared under SAP. This supplemental statutory data should not be viewed as an alternative to, or used in lieu of, U.S. GAAP. This supplemental statutory data includes the impact from in-force rate actions on pre-tax long-term care insurance statutory earnings. Statutory pre-tax earnings represent the net gain from operations, including the impact from in-force rate actions, before dividends to policyholders, refunds to members and federal income taxes and before realized capital gains or (losses). Management uses and provides this supplemental statutory data because it believes it provides a useful measure of, among other things, statutory pre-tax earnings and the adequacy of capital. Management uses this data to measure against its policy to manage its legacy insurance subsidiaries with internally generated capital. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 4

------

![](a4q25quarterlyfinancials005.jpg)

Results of Operations and Selected Operating Performance Measures The company allocates tax to its businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. The annually-determined tax rates and adjustments to each segment's provision for income taxes are estimates which are subject to review and could change from year to year. U.S. GAAP generally requires an annualized effective tax rate to be used for interim reporting periods, utilizing projections of full year results. However, in certain circumstances, it is appropriate to record the actual effective tax rate for the period if a reliable estimate cannot be made for the full year. For the first three quarters of 2025 and the second and third quarters of 2024, the company utilized the actual effective tax rate for the interim period to record the provision for income taxes for its Closed Block segment and the annualized projected effective tax rate for its Enact segment and Corporate and Other. For the first quarter of 2024, the company used the annualized projected effective tax rate for both segments and Corporate and Other. This financial supplement contains selected operating performance measures including "new insurance written," "insurance in-force" and "risk in-force," which are commonly used in the insurance industry as measures of operating performance. Management regularly monitors and reports new insurance written for the company's Enact segment as a measure of volume of new business generated in a period. The company considers new insurance written to be a measure of the operating performance of its Enact segment because it represents a measure of new sales of mortgage insurance policies during a specified period, rather than a measure of revenues or profitability during that period. Management regularly monitors and reports insurance in-force and risk in-force for the company's Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by the company's U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. These metrics are presented on a direct basis and exclude reinsurance. The company considers insurance in-force and risk in-force to be measures of the operating performance of its Enact segment because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period. Management regularly monitors and reports a loss ratio for the company's Enact segment. The company considers the loss ratio, which is the ratio of benefits and other changes in policy reserves to net earned premiums, to be a measure of underwriting performance. The company believes the loss ratio helps to enhance the understanding of the operating performance of the Enact segment. Management regularly monitors and reports insurance in-force for the life insurance products in its Closed Block segment. Insurance in-force for the company's life insurance products is a measure of the aggregate face value of outstanding insurance policies as of the respective reporting date. The company considers insurance in-force to be a measure of the operating performance of the life insurance products in its Closed Block segment because it represents a measure of the size of the business at a specific date, rather than a measure of revenues or profitability during that period. These operating performance measures enable the company to compare its operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 5

------

![](a4q25quarterlyfinancials006.jpg)

Financial Highlights (amounts in millions, except per share data) December 31, September 30, June 30, March 31, December 31, Balance Sheet Data 2025 2025 2025 2025 2024 Total Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss) $10,074 $10,158 $10,111 $10,082 $10,087 Total accumulated other comprehensive income (loss)(1) (1,324) (1,396) (1,373) (1,422) (1,643) Total Genworth Financial, Inc.'s stockholders' equity $8,750 $8,762 $8,738 $8,660 $8,444 Book value per share $22.33 $21.76 $21.22 $20.82 $20.04 Book value per share, excluding accumulated other comprehensive income (loss) $25.71 $25.22 $24.56 $24.24 $23.94 Common shares outstanding as of the balance sheet date 391.8 402.7 411.7 415.9 421.4 Twelve months ended December 31, September 30, June 30, March 31, December 31, Twelve Month Rolling Average ROE 2025 2025 2025 2025 2024 U.S. GAAP Basis ROE 2.2 % 2.2 % 1.9 % 2.1 % 3.0 % Operating ROE(2) 1.4 % 1.5 % 1.8 % 2.4 % 2.7 % Three months ended December 31, September 30, June 30, March 31, December 31, Quarterly Average ROE 2025 2025 2025 2025 2024 U.S. GAAP Basis ROE 0.1 % 4.6 % 2.0 % 2.1 % — % Operating ROE(2) 0.3 % 0.7 % 2.7 % 2.0 % 0.6 % Three months ended Twelve months ended Basic and Diluted Shares December 31, 2025 December 31, 2025 Weighted-average common shares used in basic earnings per share calculations 396.4 409.0 Potentially dilutive securities: Performance stock units, restricted stock units and other equity-based awards — 5.0 Weighted-average common shares used in diluted earnings per share calculations(3) 396.4 414.0 (1)As of December 31, 2025, September 30, 2025, June 30, 2025, March 31, 2025 and December 31, 2024, total accumulated other comprehensive income (loss) includes $463 million, $142 million, $769 million, $703 million and $1,022 million, net of taxes, respectively, related to changes in the discount rate used to remeasure the liability for future policy benefits and related reinsurance recoverables. (2)See page 32 herein for a reconciliation of U.S. GAAP Basis ROE to Operating ROE. (3)Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of the loss from continuing operations for the three months ended December 31, 2025, the company was required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended December 31, 2025, as the inclusion of shares for performance stock units, restricted stock units and other equity-based awards of 6.0 million would have been antidilutive to the calculation. If the company had not incurred a loss from continuing operations for the three months ended December 31, 2025, dilutive potential weighted-average common shares outstanding would have been 402.4 million. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 6

------

![](a4q25quarterlyfinancials007.jpg)

Consolidated Quarterly Results 7

------

![](a4q25quarterlyfinancials008.jpg)

Consolidated Net Income (Loss) by Quarter (amounts in millions, except per share amounts) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Premiums $886 $886 $865 $862 $3,499 $876 $874 $855 $875 $3,480 Net investment income 785 799 802 739 3,125 793 777 808 782 3,160 Net investment gains (losses) (39) 99 (28) 27 59 (41) 66 (61) 49 13 Policy fees and other income 152 151 157 158 618 154 163 167 158 642 Total revenues 1,784 1,935 1,796 1,786 7,301 1,782 1,880 1,769 1,864 7,295 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves 1,182 1,227 1,195 1,217 4,821 1,199 1,213 1,151 1,203 4,766 Liability remeasurement (gains) losses 143 106 60 4 313 88 34 39 (8) 153 Changes in fair value of market risk benefits and associated hedges (4) (1) (10) 18 3 (3) 21 (8) (23) (13) Interest credited 97 96 94 99 386 101 102 125 125 453 Acquisition and operating expenses, net of deferrals 265 259 249 236 1,009 253 259 229 236 977 Amortization of deferred acquisition costs and intangibles 57 57 57 60 231 62 62 60 65 249 Interest expense 26 27 26 26 105 27 28 30 30 115 Total benefits and expenses 1,766 1,771 1,671 1,660 6,868 1,727 1,719 1,626 1,628 6,700 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 18 164 125 126 433 55 161 143 236 595 Provision (benefit) for income taxes 4 9 35 36 84 20 40 32 66 158 INCOME (LOSS) FROM CONTINUING OPERATIONS 14 155 90 90 349 35 121 111 170 437 Income (loss) from discontinued operations, net of taxes(1) 21 (8) (7) (5) 1 (5) (3) (1) (1) (10) NET INCOME (LOSS) 35 147 83 85 350 30 118 110 169 427 Less: net income (loss) attributable to noncontrolling interests 33 31 32 31 127 31 33 34 30 128 NET INCOME (LOSS) AVAILABLE TO GENWORTH FINANCIAL, INC.'S COMMON STOCKHOLDERS $2 $116 $51 $54 $223 $(1) $85 $76 $139 $299 Earnings (Loss) Per Share Data: Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share Basic $(0.05) $0.30 $0.14 $0.14 $0.54 $0.01 $0.20 $0.18 $0.32 $0.71 Diluted $(0.05) $0.30 $0.14 $0.14 $0.54 $0.01 $0.20 $0.17 $0.31 $0.70 Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share Basic $— $0.29 $0.12 $0.13 $0.54 $— $0.20 $0.17 $0.31 $0.69 Diluted $— $0.28 $0.12 $0.13 $0.54 $— $0.19 $0.17 $0.31 $0.68 Weighted-average common shares outstanding Basic 396.4 408.0 413.2 418.3 409.0 425.3 430.8 436.4 443.0 433.9 Diluted(2) 396.4 413.3 417.5 422.9 414.0 431.0 435.8 440.7 450.3 439.4 (1)Income (loss) from discontinued operations primarily relates to loss recoveries of $16 million recognized in the fourth quarter of 2025, and legal costs related to litigation involving the company's former lifestyle protection insurance business. (2)Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of the loss from continuing operations for the three months ended December 31, 2025, the company was required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended December 31, 2025, as the inclusion of shares for performance stock units, restricted stock units and other equity-based awards of 6.0 million would have been antidilutive to the calculation. If the company had not incurred a loss from continuing operations for the three months ended December 31, 2025, dilutive potential weighted-average common shares outstanding would have been 402.4 million. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 8

------

![](a4q25quarterlyfinancials009.jpg)

Reconciliation of Net Income (Loss) to Adjusted Operating Income (Loss) (amounts in millions, except per share amounts) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total NET INCOME (LOSS) AVAILABLE TO GENWORTH FINANCIAL, INC.'S COMMON STOCKHOLDERS $2 $116 $51 $54 $223 $(1) $85 $76 $139 $299 Add: net income (loss) attributable to noncontrolling interests 33 31 32 31 127 31 33 34 30 128 NET INCOME (LOSS) 35 147 83 85 350 30 118 110 169 427 Less: income (loss) from discontinued operations, net of taxes 21 (8) (7) (5) 1 (5) (3) (1) (1) (10) INCOME (LOSS) FROM CONTINUING OPERATIONS 14 155 90 90 349 35 121 111 170 437 Less: net income (loss) from continuing operations attributable to noncontrolling interests 33 31 32 31 127 31 33 34 30 128 INCOME (LOSS) FROM CONTINUING OPERATIONS AVAILABLE TO GENWORTH FINANCIAL, INC.'S COMMON STOCKHOLDERS (19) 124 58 59 222 4 88 77 140 309 ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS AVAILABLE TO GENWORTH FINANCIAL, INC.'S COMMON STOCKHOLDERS: Net investment (gains) losses, net(1) 38 (99) 27 (28) (62) 39 (66) 60 (50) (17) Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(2) (6) (3) (15) 19 (5) (24) 17 (10) (26) (43) (Gains) losses on early extinguishment of debt, net(3) (1) — — — (1) (2) (2) 7 (1) 2 Expenses related to restructuring — 1 — (1) — 1 — 4 7 12 Taxes on adjustments(4) (4) (6) (2) 2 (10) (3) 11 (13) 15 10 ADJUSTED OPERATING INCOME (LOSS) $8 $17 $68 $51 $144 $15 $48 $125 $85 $273 ADJUSTED OPERATING INCOME (LOSS): Enact segment 146 134 141 137 558 137 148 165 135 585 Closed Block segment Long-Term Care Insurance (159) (100) (37) (30) (326) (104) (46) (29) 3 (176) Life Insurance 13 (15) (20) (44) (66) 2 (40) (23) (33) (94) Annuities 32 19 13 11 75 3 13 22 18 56 Total Closed Block segment (114) (96) (44) (63) (317) (99) (73) (30) (12) (214) Corporate and Other (24) (21) (29) (23) (97) (23) (27) (10) (38) (98) ADJUSTED OPERATING INCOME (LOSS) $8 $17 $68 $51 $144 $15 $48 $125 $85 $273 Earnings (Loss) Per Share Data: Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share Basic $— $0.29 $0.12 $0.13 $0.54 $— $0.20 $0.17 $0.31 $0.69 Diluted $— $0.28 $0.12 $0.13 $0.54 $— $0.19 $0.17 $0.31 $0.68 Adjusted operating income (loss) per share Basic $0.02 $0.04 $0.16 $0.12 $0.35 $0.04 $0.11 $0.29 $0.19 $0.63 Diluted $0.02 $0.04 $0.16 $0.12 $0.35 $0.04 $0.11 $0.28 $0.19 $0.62 Weighted-average common shares outstanding Basic 396.4 408.0 413.2 418.3 409.0 425.3 430.8 436.4 443.0 433.9 Diluted(5) 396.4 413.3 417.5 422.9 414.0 431.0 435.8 440.7 450.3 439.4 (1)Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests (see page 30 for reconciliation). (2)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments (see page 23 for reconciliation). (3)(Gains) losses on early extinguishment of debt are net of the portion attributable to noncontrolling interests of $2 million for the three months ended June 30, 2024. (4)Taxes on adjustments include tax expense of $3 million for the three months ended December 31, 2025 and a tax benefit of $27 million for the three months ended September 30, 2025 related to a release of a portion of the valuation allowance on certain deferred tax assets. (5)Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of the loss from continuing operations for the three months ended December 31, 2025, the company was required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended December 31, 2025, as the inclusion of shares for performance stock units, restricted stock units and other equity-based awards of 6.0 million would have been antidilutive to the calculation. If the company had not incurred a loss from continuing operations for the three months ended December 31, 2025, dilutive potential weighted-average common shares outstanding would have been 402.4 million. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 9

------

![](a4q25quarterlyfinancials010.jpg)

Consolidated Balance Sheets (amounts in millions) December 31, 2025 September 30, 2025 June 30, 2025 March 31, 2025 December 31, 2024 ASSETS Investments: Fixed maturity securities available-for-sale, at fair value(1) $45,762 $46,110 $45,672 $45,668 $44,902 Equity securities, at fair value 555 546 516 496 515 Commercial mortgage loans 6,363 6,374 6,390 6,356 6,450 Less: Allowance for credit losses (59) (59) (56) (36) (39) Commercial mortgage loans, net 6,304 6,315 6,334 6,320 6,411 Policy loans 2,297 2,311 2,366 2,316 2,310 Limited partnerships 3,484 3,473 3,337 3,241 3,142 Other invested assets 770 658 643 653 648 Total investments 59,172 59,413 58,868 58,694 57,928 Cash, cash equivalents and restricted cash 2,036 2,036 1,797 1,891 2,048 Accrued investment income 603 589 556 639 607 Deferred acquisition costs 1,586 1,632 1,680 1,729 1,779 Intangible assets and goodwill 198 184 185 193 197 Reinsurance recoverable 17,860 17,872 17,599 17,681 17,616 Less: Allowance for credit losses (23) (23) (23) (25) (24) Reinsurance recoverable, net 17,837 17,849 17,576 17,656 17,592 Other assets 418 421 479 489 444 Deferred tax asset 1,800 1,801 1,693 1,676 1,731 Market risk benefit assets 64 62 58 47 57 Separate account assets 4,369 4,449 4,394 4,192 4,438 Total assets $88,083 $88,436 $87,286 $87,206 $86,821 (1)Amortized cost of $48,150 million, $48,379 million, $48,684 million, $48,837 million and $48,720 million as of December 31, 2025, September 30, 2025, June 30, 2025, March 31, 2025 and December 31, 2024, respectively, and allowance for credit losses of $23 million, $28 million, $25 million, $14 million and $10 million as of December 31, 2025, September 30, 2025, June 30, 2025, March 31, 2025 and December 31, 2024, respectively. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 10

------

![](a4q25quarterlyfinancials011.jpg)

Consolidated Balance Sheets (amounts in millions) December 31, 2025 September 30, 2025 June 30, 2025 March 31, 2025 December 31, 2024 LIABILITIES AND EQUITY Liabilities: Future policy benefits $55,228 $55,364 $54,111 $54,158 $53,610 Policyholder account balances 13,843 14,039 14,163 14,447 14,594 Market risk benefit liabilities 413 429 453 516 465 Liability for policy and contract claims 727 710 763 698 670 Unearned premiums 92 96 101 108 115 Other liabilities 2,131 2,056 2,052 1,933 2,026 Long-term borrowings 1,513 1,520 1,520 1,519 1,518 Separate account liabilities 4,369 4,449 4,394 4,192 4,438 Liabilities related to discontinued operations(1) — 2 — 4 4 Total liabilities 78,316 78,665 77,557 77,575 77,440 Equity: Common stock 1 1 1 1 1 Additional paid-in capital 11,888 11,879 11,871 11,862 11,875 Accumulated other comprehensive income (loss): Change in the discount rate used to measure future policy benefits 463 142 769 703 1,022 All other (1,787) (1,538) (2,142) (2,125) (2,665) Total accumulated other comprehensive income (loss) (1,324) (1,396) (1,373) (1,422) (1,643) Retained earnings 1,684 1,682 1,566 1,516 1,462 Treasury stock, at cost (3,499) (3,404) (3,327) (3,297) (3,251) Total Genworth Financial, Inc.'s stockholders' equity 8,750 8,762 8,738 8,660 8,444 Noncontrolling interests 1,017 1,009 991 971 937 Total equity 9,767 9,771 9,729 9,631 9,381 Total liabilities and equity $88,083 $88,436 $87,286 $87,206 $86,821 (1)Liabilities related to discontinued operations primarily relates to legal costs related to litigation involving the sale of the company's former lifestyle protection insurance business. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 11

------

![](a4q25quarterlyfinancials012.jpg)

Consolidated Balance Sheet by Segment (amounts in millions) December 31, 2025 Enact Closed Block Corporate and Other(1) Total ASSETS Cash and investments $6,712 $53,668 $1,431 $61,811 Deferred acquisition costs and intangible assets 58 1,698 28 1,784 Reinsurance recoverable, net 4 17,833 — 17,837 Deferred tax and other assets 121 1,983 114 $2,218 Market risk benefit assets — 64 — 64 Separate account assets — 4,369 — 4,369 Total assets $6,895 $79,615 $1,573 $88,083 LIABILITIES AND EQUITY Liabilities: Future policy benefits $— $55,228 $— $55,228 Policyholder account balances — 13,843 — 13,843 Market risk benefit liabilities — 413 — 413 Liability for policy and contract claims 572 149 6 727 Unearned premiums 92 — — 92 Other liabilities 119 1,475 537 2,131 Borrowings 744 — 769 1,513 Separate account liabilities — 4,369 — 4,369 Liabilities related to discontinued operations — — — — Total liabilities 1,527 75,477 1,312 78,316 Equity: Allocated equity, excluding accumulated other comprehensive income (loss) 4,376 5,022 676 10,074 Allocated accumulated other comprehensive income (loss) (25) (884) (415) (1,324) Total Genworth Financial, Inc.'s stockholders' equity 4,351 4,138 261 8,750 Noncontrolling interests 1,017 — — 1,017 Total equity 5,368 4,138 261 9,767 Total liabilities and equity $6,895 $79,615 $1,573 $88,083 (1)Includes start-up businesses, not individually reportable, that offer aging care services through the company's CareScout services business (CareScout Services) and long-term care insurance products through its CareScout insurance business (CareScout Insurance), along with certain international businesses, debt financing expenses, unallocated corporate income and expenses and eliminations of inter-segment transactions. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 12

------

![](a4q25quarterlyfinancials013.jpg)

Consolidated Balance Sheet by Segment (amounts in millions) September 30, 2025 Enact Closed Block Corporate and Other(1) Total ASSETS Cash and investments $6,691 $53,866 $1,481 $62,038 Deferred acquisition costs and intangible assets 57 1,745 14 1,816 Reinsurance recoverable, net 4 17,845 — 17,849 Deferred tax and other assets 123 1,984 115 2,222 Market risk benefit assets — 62 — 62 Separate account assets — 4,449 — 4,449 Total assets $6,875 $79,951 $1,610 $88,436 LIABILITIES AND EQUITY Liabilities: Future policy benefits $— $55,364 $— $55,364 Policyholder account balances — 14,039 — 14,039 Market risk benefit liabilities — 429 — 429 Liability for policy and contract claims 572 132 6 710 Unearned premiums 96 — — 96 Other liabilities 134 1,362 560 2,056 Borrowings 744 — 776 1,520 Separate account liabilities — 4,449 — 4,449 Liabilities related to discontinued operations — — 2 2 Total liabilities 1,546 75,775 1,344 78,665 Equity: Allocated equity, excluding accumulated other comprehensive income (loss) 4,354 5,177 676 10,207 Allocated accumulated other comprehensive income (loss) (34) (951) (410) (1,395) Total Genworth Financial, Inc.'s stockholders' equity 4,320 4,176 266 8,762 Noncontrolling interests 1,009 — — 1,009 Total equity 5,329 4,176 266 9,771 Total liabilities and equity $6,875 $79,951 $1,610 $88,436 (1)Includes other businesses not individually reportable, including CareScout Services, CareScout Insurance and certain international businesses, along with debt financing expenses, unallocated corporate income and expenses and eliminations of inter-segment eliminations. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 13

------

![](a4q25quarterlyfinancials014.jpg)

Enact Segment 14

------

![](a4q25quarterlyfinancials015.jpg)

Adjusted Operating Income (Loss) - Enact Segment (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Premiums $245 $245 $245 $245 $980 $246 $249 $244 $241 $980 Net investment income 69 68 66 63 266 62 62 59 57 240 Net investment gains (losses) (3) (2) (8) (3) (16) (7) (1) (8) (6) (22) Policy fees and other income 1 1 1 2 5 1 — 3 — 4 Total revenues 312 312 304 307 1,235 302 310 298 292 1,202 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves 18 36 25 31 110 24 12 (17) 20 39 Acquisition and operating expenses, net of deferrals 57 51 50 50 208 55 53 65 51 224 Amortization of deferred acquisition costs and intangibles 2 2 3 2 9 3 3 2 2 10 Interest expense 13 13 12 12 50 12 13 13 13 51 Total benefits and expenses 90 102 90 95 377 94 81 63 86 324 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 222 210 214 212 858 208 229 235 206 878 Provision (benefit) for income taxes 45 47 46 46 184 45 49 51 45 190 INCOME (LOSS) FROM CONTINUING OPERATIONS 177 163 168 166 674 163 180 184 161 688 Less: net income (loss) attributable to noncontrolling interests 33 31 32 31 127 31 33 34 30 128 INCOME (LOSS) FROM CONTINUING OPERATIONS AVAILABLE TO GENWORTH FINANCIAL, INC.'S COMMON STOCKHOLDERS 144 132 136 135 547 132 147 150 131 560 ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS AVAILABLE TO GENWORTH FINANCIAL, INC.'S COMMON STOCKHOLDERS: Net investment (gains) losses, net(1) 2 2 7 2 13 5 1 7 5 18 (Gains) losses on early extinguishment of debt, net(2) — — — — — — — 9 — 9 Expenses related to restructuring — 1 (1) 1 1 1 — 3 — 4 Taxes on adjustments — (1) (1) (1) (3) (1) — (4) (1) (6) ADJUSTED OPERATING INCOME (LOSS) $146 $134 $141 $137 $558 $137 $148 $165 $135 $585 (1)Net investment (gains) losses were adjusted for the portion of net investment gain (losses) attributable to noncontrolling interests as reconciled below: Net investment (gains) losses, gross $3 $2 $8 $3 $16 $7 $1 $8 $6 $22 Adjustment for net investment gains (losses) attributable to noncontrolling interests (1) — (1) (1) (3) (2) — (1) (1) (4) Net investment (gains) losses, net $2 $2 $7 $2 $13 $5 $1 $7 $5 $18 (2)(Gains) losses on early extinguishment of debt are net of the portion attributable to noncontrolling interests of $2 million for the three months ended June 30, 2024. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 15

------

![](a4q25quarterlyfinancials016.jpg)

Selected Operating Metrics - Enact Segment (dollar amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total Direct Primary New Insurance Written $14,386 $14,048 $13,254 $9,818 $51,506 $13,266 $13,591 $13,619 $10,526 $51,002 Direct Primary Insurance In-Force $273,147 $272,349 $269,754 $268,366 $268,825 $268,003 $266,060 $263,645 Direct Primary Risk In-Force $71,363 $71,144 $70,401 $69,937 $69,985 $69,611 $68,878 $67,950 Primary Delinquencies 24,885 23,382 22,118 22,349 24,885 23,566 21,027 19,051 19,492 23,566 New Delinquencies 13,679 12,998 11,567 12,237 50,481 13,717 12,964 10,461 11,395 48,537 Paid Claims (287) (253) (218) (179) (937) (191) (220) (160) (172) (743) Primary Cures(1) (11,889) (11,481) (11,580) (13,275) (48,225) (10,987) (10,768) (10,742) (12,163) (44,660) Loss Ratio(2) 7 % 15 % 10 % 12 % 11 % 10 % 5 % (7) % 8 % 4 % Available Assets Above PMIERs Requirements(3) $1,919 $1,904 $1,961 $1,966 $2,052 $2,190 $2,057 $1,883 PMIERs Sufficiency Ratio(3) 162 % 162 % 165 % 165 % 167 % 173 % 169 % 163 % Reserves: Direct primary case(4) $515 $520 $500 $489 $472 $461 $462 $486 All other(4) 57 52 52 54 53 49 46 46 Total Reserves $572 $572 $552 $543 $525 $510 $508 $532 (1)Includes rescissions and claim denials. (2)The loss ratio is calculated using whole dollars and may be different than the ratio calculated using the rounded numbers included herein. (3)The Private Mortgage Insurer Eligibility Requirements (PMIERs) sufficiency ratio is calculated as available assets divided by required assets as defined within PMIERs. The current period PMIERs sufficiency ratio is an estimate due to the timing of the PMIERs filing. (4)Direct primary case reserves exclude loss adjustment expenses (LAE), pool, incurred but not reported (IBNR) and reinsurance reserves. Other includes LAE, pool, IBNR and reinsurance reserves. For additional information related to the Enact segment, refer to the current quarter Quarterly Financial Supplement posted to the Enact Holdings, Inc. investor page: https://ir.enactmi.com/financials-and-filings/quarterly-results GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 16

------

![](a4q25quarterlyfinancials017.jpg)

Closed Block Segment 17

------

![](a4q25quarterlyfinancials018.jpg)

Adjusted Operating Income (Loss) - Closed Block Segment (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Premiums $637 $639 $617 $615 $2,508 $627 $623 $608 $631 $2,489 Net investment income 711 726 732 671 2,840 726 711 744 718 2,899 Net investment gains (losses) (28) 93 8 30 103 (29) 67 (51) 59 46 Policy fees and other income 150 150 156 156 612 153 163 164 158 638 Total revenues 1,470 1,608 1,513 1,472 6,063 1,477 1,564 1,465 1,566 6,072 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves 1,166 1,194 1,171 1,188 4,719 1,177 1,202 1,171 1,186 4,736 Liability remeasurement (gains) losses 143 106 60 4 313 88 34 39 (8) 153 Changes in fair value of market risk benefits and associated hedges (4) (1) (10) 18 3 (3) 21 (8) (23) (13) Interest credited 97 96 94 99 386 101 102 125 125 453 Acquisition and operating expenses, net of deferrals 173 178 170 167 688 179 181 142 156 658 Amortization of deferred acquisition costs and intangibles 53 54 53 57 217 58 58 57 62 235 Total benefits and expenses 1,628 1,627 1,538 1,533 6,326 1,600 1,598 1,526 1,498 6,222 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (158) (19) (25) (61) (263) (123) (34) (61) 68 (150) Provision (benefit) for income taxes (27) 2 1 (7) (31) (20) — 1 14 (5) INCOME (LOSS) FROM CONTINUING OPERATIONS (131) (21) (26) (54) (232) (103) (34) (62) 54 (145) ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS: Net investment (gains) losses 28 (93) (8) (30) (103) 29 (67) 51 (59) (46) Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(1) (6) (3) (15) 19 (5) (24) 17 (10) (26) (43) Expenses related to restructuring — — — — — — — — 1 1 Taxes on adjustments (5) 21 5 2 23 (1) 11 (9) 18 19 ADJUSTED OPERATING INCOME (LOSS) $(114) $(96) $(44) $(63) $(317) $(99) $(73) $(30) $(12) $(214) (1)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments (see page 23 for reconciliation). GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 18

------

![](a4q25quarterlyfinancials019.jpg)

Adjusted Operating Income (Loss) - Closed Block Segment - Long-Term Care Insurance (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Premiums $598 $597 $578 $571 $2,344 $587 $581 $564 $578 $2,310 Net investment income 496 505 516 451 1,968 499 483 494 464 1,940 Net investment gains (losses) (22) 104 25 29 136 (21) 71 (47) 63 66 Policy fees and other income 1 — — — 1 — — — — — Total revenues 1,073 1,206 1,119 1,051 4,449 1,065 1,135 1,011 1,105 4,316 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves 981 972 951 944 3,848 955 949 934 936 3,774 Liability remeasurement (gains) losses 171 113 50 (18) 316 117 28 43 (16) 172 Acquisition and operating expenses, net of deferrals 120 118 115 109 462 121 118 82 102 423 Amortization of deferred acquisition costs and intangibles 16 17 16 17 66 17 17 18 17 69 Total benefits and expenses 1,288 1,220 1,132 1,052 4,692 1,210 1,112 1,077 1,039 4,438 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (215) (14) (13) (1) (243) (145) 23 (66) 66 (122) Provision (benefit) for income taxes (39) 4 4 6 (25) (24) 13 — 14 3 INCOME (LOSS) FROM CONTINUING OPERATIONS (176) (18) (17) (7) (218) (121) 10 (66) 52 (125) ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS: Net investment (gains) losses 22 (104) (25) (29) (136) 21 (71) 47 (63) (66) Expenses related to restructuring — — — — — — — — 1 1 Taxes on adjustments (5) 22 5 6 28 (4) 15 (10) 13 14 ADJUSTED OPERATING INCOME (LOSS) $(159) $(100) $(37) $(30) $(326) $(104) $(46) $(29) $3 $(176) Liability remeasurement (gains) losses(1),(2): Cash flow assumption updates $47 $6 $8 $(1) $60 $20 $(63) $(24) $(2) $(69) Actual variances from expected experience 124 107 42 (17) 256 97 91 67 (14) 241 Total $171 $113 $50 $(18) $316 $117 $28 $43 $(16) $172 Ratio of the liability remeasurement (gains) losses to beginning reserves(3) 0.40 % 0.27 % 0.11 % (0.04) % 0.74 % 0.28 % 0.07 % 0.10 % (0.04) % 0.41 % (1)In the fourth quarter of 2025, the liability remeasurement loss of $171 million in the company's block long-term care insurance products included an unfavorable impact from annual cash flow assumption updates of $47 million. Unfavorable benefit utilization and healthy life assumption updates were largely offset by favorable assumption updates reflecting in-force rate action approval experience and benefit reductions as well as favorable claim termination assumption updates. Also included in the liability remeasurement loss of $171 million were unfavorable actual variances from expected experience of $124 million associated with higher claims and lower terminations. (2)In the fourth quarter of 2024, the liability remeasurement loss of $117 million in the company's long-term care insurance products included an unfavorable impact from annual cash flow assumption updates of $20 million reflecting updates to better align healthy life and near-term benefit utilization assumptions with recent experience, including cost of care inflation. These unfavorable impacts were partially offset by favorable assumption updates for future in-force rate action approvals based on recent experience and short-term incidence assumptions for incurred but not reported claims. Also included in the liability remeasurement loss of $117 million were unfavorable actual variances from expected experience of $97 million associated with lower terminations and higher claims. (3)The ratio of the liability remeasurement (gains) losses to beginning reserves is calculated by dividing the liability remeasurement (gains) losses by the beginning liability for future policy benefits at the locked-in discount rate as of each applicable quarter. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 19

------

![](a4q25quarterlyfinancials020.jpg)

Statutory Impact of In-Force Rate Actions - Closed Block Segment - Long-Term Care Insurance (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total Impact of in-force rate actions on pre-tax statutory earnings(1) Premiums, premium tax, commissions and other expenses, net(2) $261 $256 $247 $240 $1,004 $245 $232 $220 $217 $914 Reserve changes(2) 50 81 95 97 323 97 90 102 114 403 Settlement impacts - reserve changes — — — 5 5 19 133 222 240 614 Settlement impacts - litigation expenses and settlement payments — — — (2) (2) (6) (45) (99) (109) (259) Settlement impacts, net — — — 3 3 13 88 123 131 355 Statutory earnings from in-force rate actions $311 $337 $342 $340 $1,330 $355 $410 $445 $462 $1,672 (1)Includes all implemented in-force rate actions since 2012. (2)Earned premium and reserve change estimates for statutory earnings reflect certain simplifying assumptions that may vary materially from actual historical results, including but not limited to, a uniform rate of coinsurance and premium taxes in addition to consistent policyholder behavior over time. Actual behavior may differ significantly from these assumptions and these impacts exclude reserve updates. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 20

------

![](a4q25quarterlyfinancials021.jpg)

Adjusted Operating Income (Loss) - Closed Block Segment - Life Insurance (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Premiums $39 $42 $39 $44 $164 $40 $42 $44 $53 $179 Net investment income 144 148 139 144 575 147 146 167 167 627 Net investment gains (losses) (1) (3) (9) — (13) (3) (2) 5 5 5 Policy fees and other income 123 123 130 129 505 125 135 136 129 525 Total revenues 305 310 299 317 1,231 309 321 352 354 1,336 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves 151 186 183 201 721 187 213 200 208 808 Liability remeasurement (gains) losses (6) — 9 25 28 (28) 5 — 11 (12) Interest credited 77 75 73 77 302 78 78 101 99 356 Acquisition and operating expenses, net of deferrals 36 39 36 36 147 38 41 43 35 157 Amortization of deferred acquisition costs and intangibles 32 32 33 34 131 35 36 33 38 142 Total benefits and expenses 290 332 334 373 1,329 310 373 377 391 1,451 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 15 (22) (35) (56) (98) (1) (52) (25) (37) (115) Provision (benefit) for income taxes 3 (4) (8) (12) (21) (1) (11) (5) (8) (25) INCOME (LOSS) FROM CONTINUING OPERATIONS 12 (18) (27) (44) (77) — (41) (20) (29) (90) ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS: Net investment (gains) losses 1 3 9 — 13 3 2 (5) (5) (5) Taxes on adjustments — — (2) — (2) (1) (1) 2 1 1 ADJUSTED OPERATING INCOME (LOSS) $13 $(15) $(20) $(44) $(66) $2 $(40) $(23) $(33) $(94) Liability remeasurement (gains) losses(1),(2): Cash flow assumption updates $(15) $— $— $— $(15) $28 $— $— $— $28 Actual variances from expected experience 9 — 9 25 43 (56) 5 — 11 (40) Total $(6) $— $9 $25 $28 $(28) $5 $— $11 $(12) (1)In the fourth quarter of 2025, the company had a favorable pre-tax impact of $15 million from cash flow assumption updates in its universal and term universal life insurance products reflecting favorable updates to interest rate assumptions given the recent rate environment. (2)In the fourth quarter of 2024, the liability remeasurement gain of $28 million reflected net favorable model and cash flow assumption updates of $30 million, partially offset by an unfavorable update to mortality assumptions for universal life insurance contracts originating from term life insurance conversions and unfavorable interest rate assumption updates. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 21

------

![](a4q25quarterlyfinancials022.jpg)

Insurance In-Force - Closed Block Segment - Life Insurance (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q 4Q 3Q 2Q 1Q Term and whole life insurance Life insurance in-force, net of reinsurance $38,550 $39,299 $40,066 $40,970 $41,386 $42,072 $42,839 $43,512 Life insurance in-force, before reinsurance $204,019 $212,145 $221,136 $230,338 $238,865 $247,682 $255,881 $263,727 Term universal life insurance Life insurance in-force, net of reinsurance $84,373 $85,722 $87,101 $88,113 $88,700 $89,137 $89,608 $90,054 Life insurance in-force, before reinsurance $84,912 $86,276 $87,654 $88,684 $89,283 $89,723 $90,200 $90,648 Universal life insurance Life insurance in-force, net of reinsurance $26,063 $26,334 $26,622 $26,918 $27,228 $27,677 $28,010 $28,306 Life insurance in-force, before reinsurance $29,223 $29,582 $29,906 $30,257 $30,583 $31,102 $31,489 $31,831 GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 22

------

![](a4q25quarterlyfinancials023.jpg)

Adjusted Operating Income (Loss) - Closed Block Segment - Annuities (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Net investment income $71 $73 $77 $76 $297 $80 $82 $83 $87 $332 Net investment gains (losses) (5) (8) (8) 1 (20) (5) (2) (9) (9) (25) Policy fees and other income 26 27 26 27 106 28 28 28 29 113 Total revenues 92 92 95 104 $383 103 108 102 107 420 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves 34 36 37 43 $150 35 40 37 42 154 Liability remeasurement (gains) losses (22) (7) 1 (3) (31) (1) 1 (4) (3) (7) Changes in fair value of market risk benefits and associated hedges (4) (1) (10) 18 3 (3) 21 (8) (23) (13) Interest credited 20 21 21 22 84 23 24 24 26 97 Acquisition and operating expenses, net of deferrals 17 21 19 22 79 20 22 17 19 78 Amortization of deferred acquisition costs and intangibles 5 5 4 6 20 6 5 6 7 24 Total benefits and expenses 50 75 72 108 305 80 113 72 68 333 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 42 17 23 (4) 78 23 (5) 30 39 87 Provision (benefit) for income taxes 9 2 5 (1) 15 5 (2) 6 8 17 INCOME (LOSS) FROM CONTINUING OPERATIONS 33 15 18 (3) 63 18 (3) 24 31 70 ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS: Net investment (gains) losses 5 8 8 (1) 20 5 2 9 9 25 Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(1) (6) (3) (15) 19 (5) (24) 17 (10) (26) (43) Taxes on adjustments — (1) 2 (4) (3) 4 (3) (1) 4 4 ADJUSTED OPERATING INCOME (LOSS) $32 $19 $13 $11 $75 $3 $13 $22 $18 $56 Liability remeasurement (gains) losses: Cash flow assumption updates(2) $(22) $— $— $— $(22) $(1) $— $— $— $(1) Actual variances from expected experience — (7) 1 (3) (9) — 1 (4) (3) (6) Total $(22) $(7) $1 $(3) $(31) $(1) $1 $(4) $(3) $(7) (1)Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments as reconciled below: Changes in fair value of market risk benefits and associated hedges $(4) $(1) $(10) $18 $3 $(3) $21 $(8) $(23) $(13) Adjustment for changes in reserves, attributed fees and benefit payments (2) (2) (5) 1 (8) (21) (4) (2) (3) (30) Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges $(6) $(3) $(15) $19 $(5) $(24) $17 $(10) $(26) $(43) (2)In the fourth quarter of 2025, the company's annuity products had a favorable pre-tax impact of $22 million primarily from favorable updates to its fixed annuity mortality assumptions. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 23

------

![](a4q25quarterlyfinancials024.jpg)

Corporate and Other 24

------

![](a4q25quarterlyfinancials025.jpg)

Adjusted Operating Income (Loss) - Corporate and Other(1) (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total REVENUES: Premiums $4 $2 $3 $2 $11 $3 $2 $3 $3 $11 Net investment income 5 5 4 5 19 5 4 5 7 21 Net investment gains (losses) (8) 8 (28) — (28) (5) — (2) (4) (11) Policy fees and other income 1 — — — 1 — — — — — Total revenues 2 15 (21) 7 3 3 6 6 6 21 BENEFITS AND EXPENSES: Benefits and other changes in policy reserves (2) (3) (1) (2) (8) (2) (1) (3) (3) (9) Acquisition and operating expenses, net of deferrals 35 30 29 19 113 19 25 22 29 95 Amortization of deferred acquisition costs and intangibles 2 1 1 1 5 1 1 1 1 4 Interest expense 13 14 14 14 55 15 15 17 17 64 Total benefits and expenses 48 42 43 32 165 33 40 37 44 154 INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES (46) (27) (64) (25) (162) (30) (34) (31) (38) (133) Provision (benefit) for income taxes (14) (40) (12) (3) (69) (5) (9) (20) 7 (27) INCOME (LOSS) FROM CONTINUING OPERATIONS (32) 13 (52) (22) (93) (25) (25) (11) (45) (106) ADJUSTMENTS TO INCOME (LOSS) FROM CONTINUING OPERATIONS: Net investment (gains) losses 8 (8) 28 — 28 5 — 2 4 11 (Gains) losses on early extinguishment of debt (1) — — — (1) (2) (2) (2) (1) (7) Expenses related to restructuring — — 1 (2) (1) — — 1 6 7 Taxes on adjustments(2) 1 (26) (6) 1 (30) (1) — — (2) (3) ADJUSTED OPERATING INCOME (LOSS) $(24) $(21) $(29) $(23) $(97) $(23) $(27) $(10) $(38) $(98) (1)Includes other businesses not individually reportable, including CareScout Services, CareScout Insurance and certain international businesses, along with debt financing expenses, unallocated corporate income and expenses and eliminations of inter-segment eliminations. (2)Taxes on adjustments include tax expense of $3 million for the three months ended December 31, 2025 and a tax benefit of $27 million for the three months ended September 30, 2025 related to a release of a portion of the valuation allowance on certain deferred tax assets. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 25

------

![](a4q25quarterlyfinancials026.jpg)

Additional Financial Data 26

------

![](a4q25quarterlyfinancials027.jpg)

Investments Summary (amounts in millions) December 31, 2025 September 30, 2025 June 30, 2025 March 31, 2025 December 31, 2024 Carrying Amount % of Total Carrying Amount % of Total Carrying Amount % of Total Carrying Amount % of Total Carrying Amount % of Total Composition of Investment Portfolio Fixed maturity securities: Investment grade: Public fixed maturity securities $26,493 44 % $26,839 45 % $26,326 43 % $26,470 43 % $26,159 44 % Private fixed maturity securities 11,333 19 11,305 18 11,341 19 11,166 18 10,882 18 Residential mortgage-backed securities(1) 1,099 2 1,059 2 1,044 2 911 2 811 1 Commercial mortgage-backed securities 1,295 2 1,346 2 1,331 2 1,309 2 1,293 2 Other asset-backed securities 2,060 3 2,035 3 2,026 3 2,134 4 2,120 4 State and political subdivisions 2,114 3 2,145 3 2,135 4 2,169 4 2,149 4 Non-investment grade fixed maturity securities 1,368 2 1,381 2 1,469 2 1,509 2 1,488 2 Equity securities: Common stocks and mutual funds 485 1 477 1 447 1 415 1 429 1 Preferred stocks 70 — 69 — 69 — 81 — 86 — Commercial mortgage loans, net 6,304 10 6,315 10 6,334 10 6,320 11 6,411 11 Policy loans 2,297 4 2,311 4 2,366 4 2,316 4 2,310 4 Limited partnerships 3,484 6 3,473 6 3,337 6 3,241 5 3,142 5 Cash, cash equivalents, restricted cash and short-term investments 2,073 3 2,062 3 1,808 3 1,895 3 2,052 3 Other invested assets: Derivatives: Interest rate swaps 11 — 17 — 16 — 23 — 18 — Foreign currency swaps 4 — 5 — 3 — 12 — 13 — Equity index options 18 — 19 — 17 — 12 — 19 — Forward bond purchase commitments 6 — 11 — 6 — 19 — 6 — Foreign currency forward contracts — — — — — — 1 — — — Other 694 1 580 1 590 1 582 1 588 1 Total invested assets and cash $61,208 100 % $61,449 100 % $60,665 100 % $60,585 100 % $59,976 100 % Public Fixed Maturity Securities - Credit Quality: NRSRO(2) Designation AAA $1,466 5 % $1,496 5 % $1,498 5 % $2,467 8 % $2,414 8 % AA 7,250 23 7,166 23 7,063 23 6,158 20 5,988 20 A 9,373 30 9,440 30 9,031 29 8,809 28 8,537 28 BBB 12,642 40 12,993 40 12,951 41 13,165 42 13,208 42 BB 504 2 476 2 488 2 477 2 476 2 B 16 — 34 — 46 — 27 — 27 — CCC and lower — — — — — — — — — — Total public fixed maturity securities $31,251 100 % $31,605 100 % $31,077 100 % $31,103 100 % $30,650 100 % Private Fixed Maturity Securities - Credit Quality: NRSRO(2) Designation AAA $540 4 % $599 4 % $652 4 % $766 5 % $777 5 % AA 1,690 12 1,600 11 1,580 11 1,506 10 1,527 11 A 4,484 31 4,410 31 4,310 30 4,136 28 4,015 28 BBB 6,949 48 7,025 49 7,118 49 7,152 50 6,948 49 BB 747 5 773 5 828 6 889 6 850 6 B 71 — 66 — 71 — 73 1 81 1 CCC and lower 15 — 17 — 21 — 28 — 39 — Not rated 15 — 15 — 15 — 15 — 15 — Total private fixed maturity securities $14,511 100 % $14,505 100 % $14,595 100 % $14,565 100 % $14,252 100 % (1)The company does not have any material exposure to residential mortgage-backed securities collateralized debt obligations (CDOs). (2)Nationally Recognized Statistical Rating Organizations. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 27

------

![](a4q25quarterlyfinancials028.jpg)

Fixed Maturity Securities Summary (amounts in millions) December 31, 2025 September 30, 2025 June 30, 2025 March 31, 2025 December 31, 2024 Fair Value % of Total Fair Value % of Total Fair Value % of Total Fair Value % of Total Fair Value % of Total Fixed Maturity Securities - Security Sector: U.S. government, agencies and government-sponsored enterprises $3,701 8 % $3,593 8 % $3,527 8 % $3,594 8 % $3,493 8 % State and political subdivisions 2,114 5 2,145 5 2,135 5 2,169 5 2,149 5 Foreign government 1,215 3 1,203 3 1,121 2 1,029 2 909 2 U.S. corporate 27,046 58 27,391 59 27,154 59 27,229 59 26,771 59 Foreign corporate 7,191 16 7,301 16 7,302 16 7,260 16 7,327 16 Residential mortgage-backed securities 1,100 2 1,059 2 1,044 2 911 2 811 2 Commercial mortgage-backed securities 1,309 3 1,360 3 1,340 3 1,318 3 1,301 3 Other asset-backed securities 2,086 5 2,058 4 2,049 5 2,158 5 2,141 5 Total fixed maturity securities $45,762 100 % $46,110 100 % $45,672 100 % $45,668 100 % $44,902 100 % Corporate Bond Holdings - Industry Sector: Investment Grade: Finance and insurance $8,666 26 % $8,675 25 % $8,587 25 % $8,532 25 % $8,546 26 % Utilities 5,107 15 5,149 15 5,043 15 4,991 15 4,899 14 Energy 3,252 10 3,292 10 3,265 10 3,253 9 3,167 9 Consumer - non-cyclical 4,839 14 4,928 15 4,871 14 4,884 15 4,822 14 Consumer - cyclical 1,298 3 1,375 4 1,403 4 1,474 4 1,471 4 Capital goods 2,894 9 2,876 8 2,818 8 2,791 8 2,699 8 Industrial 1,536 4 1,653 5 1,641 5 1,679 5 1,689 5 Technology and communications 3,250 9 3,365 9 3,345 9 3,365 9 3,268 10 Transportation 1,560 5 1,508 4 1,495 4 1,502 4 1,485 4 Other 667 2 688 2 697 2 700 2 744 2 Subtotal 33,069 97 33,509 97 33,165 96 33,171 96 32,790 96 Non-Investment Grade: Finance and insurance 110 — 128 — 135 — 140 1 139 — Utilities 45 — 49 — 69 — 73 — 76 1 Energy 144 — 126 — 129 — 163 1 151 1 Consumer - non-cyclical 124 — 127 — 137 1 123 — 121 — Consumer - cyclical 201 1 228 1 249 1 258 1 256 1 Capital goods 117 — 136 1 143 1 133 — 135 — Industrial 179 1 144 — 166 — 166 — 149 1 Technology and communications 188 1 184 1 206 1 181 1 181 — Transportation — — — — — — 25 — 25 — Other 60 — 61 — 57 — 56 — 75 — Subtotal 1,168 3 1,183 3 1,291 4 1,318 4 1,308 4 Total $34,237 100 % $34,692 100 % $34,456 100 % $34,489 100 % $34,098 100 % Fixed Maturity Securities - Contractual Maturity Dates: Due in one year or less $1,543 3 % $1,648 4 % $1,481 3 % $1,413 3 % $1,419 3 % Due after one year through five years 8,306 18 8,309 18 8,573 19 8,474 19 7,895 18 Due after five years through ten years 11,221 25 11,230 24 11,040 24 11,132 24 11,431 25 Due after ten years 20,197 44 20,446 45 20,145 44 20,262 44 19,904 44 Subtotal 41,267 90 41,633 91 41,239 90 41,281 90 40,649 90 Mortgage and asset-backed securities 4,495 10 4,477 9 4,433 10 4,387 10 4,253 10 Total fixed maturity securities $45,762 100 % $46,110 100 % $45,672 100 % $45,668 100 % $44,902 100 % GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 28

------

![](a4q25quarterlyfinancials029.jpg)

U.S. GAAP Net Investment Income Yields (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total U.S. GAAP Net Investment Income Fixed maturity securities - taxable $561 $565 $570 $559 $2,255 $556 $557 $571 $554 $2,238 Fixed maturity securities - non-taxable — 1 — — 1 1 — — 1 2 Equity securities 4 3 3 3 13 5 3 3 2 13 Commercial mortgage loans 75 74 72 73 294 73 74 75 75 297 Policy loans 37 39 32 36 144 37 38 56 58 189 Limited partnerships 56 62 69 8 195 60 36 36 20 152 Other invested assets 61 64 62 61 248 65 70 67 68 270 Cash, cash equivalents, restricted cash and short-term investments 21 18 19 22 80 23 24 25 27 99 Gross investment income before expenses and fees 815 826 827 762 3,230 820 802 833 805 3,260 Expenses and fees (30) (27) (25) (23) (105) (27) (25) (25) (23) (100) Net investment income $785 $799 $802 $739 $3,125 $793 $777 $808 $782 $3,160 Annualized Yields Fixed maturity securities - taxable 4.7 % 4.7 % 4.7 % 4.6 % 4.6 % 4.6 % 4.6 % 4.7 % 4.5 % 4.6 % Fixed maturity securities - non-taxable — % 19.0 % — % — % 4.2 % 11.8 % — % — % 10.8 % 5.7 % Equity securities 2.9 % 2.3 % 2.4 % 2.4 % 2.5 % 4.1 % 2.7 % 2.8 % 1.9 % 2.9 % Commercial mortgage loans 4.8 % 4.7 % 4.6 % 4.6 % 4.6 % 4.5 % 4.5 % 4.5 % 4.4 % 4.5 % Policy loans 6.4 % 6.7 % 5.5 % 6.2 % 6.2 % 6.4 % 6.5 % 9.8 % 10.5 % 8.3 % Limited partnerships(1) 6.4 % 7.3 % 8.4 % 1.0 % 5.8 % 7.7 % 4.7 % 4.9 % 2.8 % 5.1 % Other invested assets(2) 38.3 % 45.1 % 42.3 % 41.7 % 40.9 % 43.0 % 45.5 % 45.6 % 47.7 % 45.7 % Cash, cash equivalents, restricted cash and short-term investments 4.1 % 3.7 % 4.1 % 4.5 % 4.0 % 4.5 % 4.8 % 5.1 % 5.1 % 4.8 % Gross investment income before expenses and fees 5.1 % 5.2 % 5.2 % 4.8 % 5.1 % 5.1 % 5.0 % 5.2 % 5.0 % 5.1 % Expenses and fees (0.2) % (0.2) % (0.2) % (0.2) % (0.2) % (0.1) % (0.1) % (0.2) % (0.1) % (0.2) % Net investment income 4.9 % 5.0 % 5.0 % 4.6 % 4.9 % 5.0 % 4.9 % 5.0 % 4.9 % 4.9 % Yields are based on net investment income as reported under U.S. GAAP and are consistent with how the company measures its investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments. See page 34 herein for average invested assets and cash used in the yield calculation. (1)Limited partnership investments are primarily equity-based and do not have fixed returns by period. (2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 29

------

![](a4q25quarterlyfinancials030.jpg)

Net Investment Gains (Losses) - Detail (amounts in millions) 2025 2024 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total Realized investment gains (losses): Net realized gains (losses) on available-for-sale securities: Fixed maturity securities: U.S. corporate $(3) $(4) $(15) $— $(22) $(8) $(1) $(9) $(17) $(35) U.S. government, agencies and government-sponsored enterprises — — 1 — 1 — — 3 1 4 Foreign corporate (7) (4) (1) (2) (14) 3 (6) (7) (3) (13) Foreign government — — (3) (2) (5) (3) 2 1 — — Mortgage-backed securities (8) (2) — — (10) (1) (2) (7) (3) (13) Total net realized gains (losses) on available-for-sale securities (18) (10) (18) (4) (50) (9) (7) (19) (22) (57) Net realized gains (losses) on equity securities sold — — 4 1 5 9 — — — 9 Total net realized investment gains (losses) (18) (10) (14) (3) (45) — (7) (19) (22) (48) Net change in allowance for credit losses on available-for-sale fixed maturity securities 5 (3) (11) (4) (13) (10) — 7 — (3) Write-down of available-for-sale fixed maturity securities — — (4) — (4) (9) — — — (9) Net unrealized gains (losses) on equity securities still held 8 30 32 (14) 56 17 22 12 32 83 Net unrealized gains (losses) on limited partnerships (17) 66 25 38 112 (3) 55 (52) 43 43 Commercial mortgage loans (3) (3) (20) 3 (23) (5) (8) (1) (2) (16) Derivative instruments (4) 17 (36) 6 (17) (21) 10 (8) 1 (18) Other (10) 2 — 1 (7) (10) (6) — (3) (19) Net investment gains (losses), gross (39) 99 (28) 27 59 (41) 66 (61) 49 13 Adjustment for net investment (gains) losses attributable to noncontrolling interests 1 — 1 1 3 2 — 1 1 4 Net investment gains (losses), net $(38) $99 $(27) $28 $62 $(39) $66 $(60) $50 $17 GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 30

------

![](a4q25quarterlyfinancials031.jpg)

Reconciliations of Non-GAAP Measures 31

------

![](a4q25quarterlyfinancials032.jpg)

Reconciliation of Operating ROE (amounts in millions) Twelve months ended Twelve Month Rolling Average ROE December 31, September 30, June 30, March 31, December 31, U.S. GAAP Basis ROE 2025 2025 2025 2025 2024 Net income (loss) available to Genworth Financial, Inc.'s common stockholders for the twelve months ended(1) $223 $220 $189 $214 $299 Quarterly average Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss)(2) $10,102 $10,124 $10,122 $10,119 $10,110 U.S. GAAP Basis ROE(1)/(2) 2.2 % 2.2 % 1.9 % 2.1 % 3.0 % Operating ROE Adjusted operating income (loss) for the twelve months ended(1) $144 $151 $182 $239 $273 Quarterly average Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss)(2) $10,102 $10,124 $10,122 $10,119 $10,110 Operating ROE(1)/(2) 1.4 % 1.5 % 1.8 % 2.4 % 2.7 % Three months ended Quarterly Average ROE December 31, September 30, June 30, March 31, December 31, U.S. GAAP Basis ROE 2025 2025 2025 2025 2024 Net income (loss) available to Genworth Financial, Inc.'s common stockholders for the period ended(3) $2 $116 $51 $54 $(1) Quarterly average Genworth Financial, Inc.'s stockholders' equity for the period, excluding accumulated other comprehensive income (loss)(4) $10,116 $10,135 $10,097 $10,085 $10,135 Annualized U.S. GAAP Quarterly Basis ROE(3)/(4) 0.1 % 4.6 % 2.0 % 2.1 % — % Operating ROE Adjusted operating income (loss) for the period ended(3) $8 $17 $68 $51 $15 Quarterly average Genworth Financial, Inc.'s stockholders' equity for the period, excluding accumulated other comprehensive income (loss)(4) $10,116 $10,135 $10,097 $10,085 $10,135 Annualized Operating Quarterly Basis ROE(3)/(4) 0.3 % 0.7 % 2.7 % 2.0 % 0.6 % Non-GAAP Definition for Operating ROE The company references the non-GAAP financial measure entitled "operating return on equity" or "operating ROE." The company defines operating ROE as adjusted operating income (loss) divided by average ending Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss). Management believes that analysis of operating ROE enhances understanding of the efficiency with which the company deploys its capital. However, operating ROE is not a substitute for net income (loss) available to Genworth Financial, Inc.'s common stockholders divided by average ending Genworth Financial, Inc.'s stockholders' equity determined in accordance with U.S. GAAP. (1)The twelve months ended information is derived by adding the four quarters of net income (loss) available to Genworth Financial, Inc.'s common stockholders and adjusted operating income (loss) from page 9 herein. (2)Quarterly average Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss), is derived by averaging ending Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss), for the most recent five quarters. (3)Net income (loss) available to Genworth Financial, Inc.'s common stockholders and adjusted operating income (loss) from page 9 herein. (4)Quarterly average Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss), is derived by averaging ending Genworth Financial, Inc.'s stockholders' equity, excluding accumulated other comprehensive income (loss), over two consecutive quarters. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 32

------

![](a4q25quarterlyfinancials033.jpg)

Reconciliation of Consolidated Expense Ratio (amounts in millions) 2025 2024 GAAP Basis Expense Ratio 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total (A) Acquisition and operating expenses, net of deferrals $265 $259 $249 $236 $1,009 $253 $259 $229 $236 $977 (B) Premiums $886 $886 $865 $862 $3,499 $876 $874 $855 $875 $3,480 (A) / (B) GAAP basis expense ratio 30 % 29 % 29 % 27 % 29 % 29 % 30 % 27 % 27 % 28 % Adjusted Expense Ratio Acquisition and operating expenses, net of deferrals $265 $259 $249 $236 $1,009 $253 $259 $229 $236 $977 Less: Legal settlement (recoveries) expenses(1) — — — — — — — (24) (4) (28) Less: (Gains) losses on early extinguishment of debt(2) (1) — — — (1) (2) (2) 9 (1) 4 (C) Adjusted acquisition and operating expenses, net of deferrals $266 $259 $249 $236 $1,010 $255 $261 $244 $241 $1,001 Premiums $886 $886 $865 $862 $3,499 $876 $874 $855 $875 $3,480 Add: Policy fees and other income 152 151 157 158 618 154 163 167 158 642 (D) Adjusted revenues $1,038 $1,037 $1,022 $1,020 $4,117 $1,030 $1,037 $1,022 $1,033 $4,122 (C) / (D) Adjusted expense ratio 26 % 25 % 24 % 23 % 25 % 25 % 25 % 24 % 23 % 24 % Non-GAAP Definition for Adjusted Expense Ratio The company references the non-GAAP financial measure entitled "adjusted expense ratio" as a measure of its operating performance. The company defines adjusted expense ratio as acquisition and operating expenses, net of deferrals, less certain reinsurance expenses, less legal settlement (recoveries) expenses incurred in the company's closed block long-term care insurance business, less (gains) losses on early extinguishment of debt divided by the sum of premiums, policy fees and other income. Management believes that the expense ratio analysis enhances understanding of the operating performance of the company. However, the adjusted expense ratio as defined by the company should not be viewed as a substitute for the GAAP basis expense ratio. (1)Estimated pre-tax class action attorney fees incurred in connection with legal settlements in the company's closed block long-term care insurance business. These amounts are accrued in the period the court settlement occurs. Amounts in the second and first quarters of 2024 represent net insurance recoveries on legal costs incurred in connection with these legal settlements. (2)(Gains) losses on early extinguishment of debt include the portion attributable to noncontrolling interests of $2 million for the three months ended June 30, 2024. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 33

------

![](a4q25quarterlyfinancials034.jpg)

Reconciliation of Reported Yield to Core Yield 2025 2024 (Assets - amounts in billions) 4Q 3Q 2Q 1Q Total 4Q 3Q 2Q 1Q Total Reported - Total Invested Assets and Cash $61.2 $61.4 $60.7 $60.6 $61.2 $60.0 $62.6 $60.3 $61.0 $60.0 Subtract: Unrealized gains (losses) (2.3) (2.2) (2.9) (3.1) (2.3) (3.8) (1.5) (3.7) (3.1) (3.8) Adjusted end of period invested assets and cash $63.5 $63.6 $63.6 $63.7 $63.5 $63.8 $64.1 $64.0 $64.1 $63.8 (A) Average Invested Assets and Cash Used in Reported and Core Yield Calculation $63.6 $63.6 $63.6 $63.7 $63.7 $63.9 $64.0 $64.0 $64.3 $64.1 (Income - amounts in millions) (B) Reported - Net Investment Income $785 $799 $802 $739 $3,125 $793 $777 $808 $782 $3,160 Subtract: Bond calls and commercial mortgage loan prepayments 3 2 1 2 8 — 1 1 1 3 Other non-core items(1) 6 2 5 2 15 5 4 4 2 15 (C) Core Net Investment Income $776 $795 $796 $735 $3,102 $788 $772 $803 $779 $3,142 (B) / (A) Reported Yield 4.94 % 5.02 % 5.04 % 4.64 % 4.91 % 4.97 % 4.86 % 5.04 % 4.87 % 4.93 % (C) / (A) Core Yield 4.88 % 5.00 % 5.00 % 4.62 % 4.87 % 4.93 % 4.82 % 5.02 % 4.85 % 4.91 % Note: Yields have been annualized. Non-GAAP Definition for Core Yield The company references the non-GAAP financial measure entitled "core yield" as a measure of investment yield. The company defines core yield as the investment yield adjusted for items that do not reflect the underlying performance of the investment portfolio. Management believes that analysis of core yield enhances understanding of the investment yield of the company. However, core yield is not a substitute for investment yield determined in accordance with U.S. GAAP. (1)Includes cost basis adjustments on structured securities and various other immaterial items. GENWORTH FINANCIAL, INC. FINANCIAL SUPPLEMENT FOURTH QUARTER 2025 34

------